Back

Exploring the benefits: experimental insights on the effects of LIM and cysteine-rich domains 1 (LMCD1) reduction on cardiac hypertrophy

12 May 2026 (08:30 - 09:30)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - experimental heart failure (3) Experimental Heart Failure Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Ms Lucia Kilian

University Medical Center of Schleswig-Holstein, Kiel (Germany)

1 More presentation in this session

Presentation thumbnail
Soluble guanylate cyclase as a therapeutic target in heart failure: modulation of oxidative stress and cardiac remodeling pathways with potential implications for heart failure therapy
Doctor B. Szeiffova Bacova (Bratislava, SK)
Abstract Slides

Access the full session

Session thumbnail
ePosters in chronic heart failure - experimental heart failure (3)

The Event

Event poster

Heart Failure 2026

12 May 2026 08:30 CET
You may be interested in
thumbnail
Congress Session
Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments
thumbnail
Congress Session
From genetic signatures to clinical implications
thumbnail
Congress Presentation
Fetal recapitulation and cellular stress in the evolution and progression of heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources